Synuclein-gamma is a member of the synuclein family of proteins, which are believed to be involved in the pathogenesis of neurodegenerative diseases. High levels of SNCG have been identified in advanced breast carcinomas suggesting a correlation between overexpression of SNCG and breast tumor development. Gamma-synuclein is a synucleinprotein found primarily in the peripheral nervous system (in primary sensory neurons, sympathetic neurons, and motor neurons) and retina. It is also detected in the brain, ovarian tumors, and in the olfactory epithelium. Gamma-synuclein is the least conserved of the synuclein proteins.
Gamma-Synucleins expression in breast tumors is a marker for tumor progression as mammalian gamma-synuclein was first identified as breast cancer-specific gene 1 (BCSG1). A change in the expression of gamma-synuclein has been observed in the retina of patients with Alzheimer's disease. The normal cellular function of gamma-synuclein remains unknown.
^Ji H, Liu YE, Jia T, Wang M, Liu J, Xiao G, Joseph BK, Rosen C, Shi YE (Mar 1997). "Identification of a breast cancer-specific gene, BCSG1, by direct differential cDNA sequencing". Cancer Res57 (4): 759–64. PMID9044857.
^Ninkina NN, Alimova-Kost MV, Paterson JW, Delaney L, Cohen BB, Imreh S, Gnuchev NV, Davies AM, Buchman VL (Oct 1998). "Organization, expression and polymorphism of the human persyn gene". Hum Mol Genet7 (9): 1417–24. doi:10.1093/hmg/7.9.1417. PMID9700196.
Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, et al. (1997). "Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library". Gene200 (1–2): 149–56. doi:10.1016/S0378-1119(97)00411-3. PMID9373149.
Lavedan C, Leroy E, Dehejia A, et al. (1998). "Identification, localization and characterization of the human gamma-synuclein gene". Hum. Genet.103 (1): 106–12. doi:10.1007/s004390050792. PMID9737786.
Buchman VL, Hunter HJ, Pinõn LG, et al. (1998). "Persyn, a member of the synuclein family, has a distinct pattern of expression in the developing nervous system". J. Neurosci.18 (22): 9335–41. PMID9801372.
Lavedan C, Buchholtz S, Auburger G, et al. (1999). "Absence of mutation in the beta- and gamma-synuclein genes in familial autosomal dominant Parkinson's disease". DNA Res.5 (6): 401–2. doi:10.1093/dnares/5.6.401. PMID10048491.
Surguchov A, Surgucheva I, Solessio E, Baehr W (1999). "Synoretin--A new protein belonging to the synuclein family". Mol. Cell. Neurosci.13 (2): 95–103. doi:10.1006/mcne.1999.0735. PMID10192768.
Duda JE, Shah U, Arnold SE, et al. (2000). "The expression of alpha-, beta-, and gamma-synucleins in olfactory mucosa from patients with and without neurodegenerative diseases". Exp. Neurol.160 (2): 515–22. doi:10.1006/exnr.1999.7228. PMID10619569.
Pronin AN, Morris AJ, Surguchov A, Benovic JL (2000). "Synucleins are a novel class of substrates for G protein-coupled receptor kinases". J. Biol. Chem.275 (34): 26515–22. doi:10.1074/jbc.M003542200. PMID10852916.
Galvin JE, Schuck TM, Lee VM, Trojanowski JQ (2001). "Differential expression and distribution of alpha-, beta-, and gamma-synuclein in the developing human substantia nigra". Exp. Neurol.168 (2): 347–55. doi:10.1006/exnr.2000.7615. PMID11259122.
Surguchov A, Palazzo RE, Surgucheva I (2002). "Gamma synuclein: subcellular localization in neuronal and non-neuronal cells and effect on signal transduction". Cell Motil. Cytoskeleton49 (4): 218–28. doi:10.1002/cm.1035. PMID11746666.
Uversky VN, Li J, Souillac P, et al. (2002). "Biophysical properties of the synucleins and their propensities to fibrillate: inhibition of alpha-synuclein assembly by beta- and gamma-synucleins". J. Biol. Chem.277 (14): 11970–8. doi:10.1074/jbc.M109541200. PMID11812782.
Lu A, Zhang F, Gupta A, Liu J (2002). "Blockade of AP1 transactivation abrogates the abnormal expression of breast cancer-specific gene 1 in breast cancer cells". J. Biol. Chem.277 (35): 31364–72. doi:10.1074/jbc.M201060200. PMID12072430.
Pan ZZ, Bruening W, Giasson BI, et al. (2002). "Gamma-synuclein promotes cancer cell survival and inhibits stress- and chemotherapy drug-induced apoptosis by modulating MAPK pathways". J. Biol. Chem.277 (38): 35050–60. doi:10.1074/jbc.M201650200. PMID12121974.
Li QX, Campbell BC, McLean CA, et al. (2003). "Platelet alpha- and gamma-synucleins in Parkinson's disease and normal control subjects". J. Alzheimers Dis.4 (4): 309–15. PMID12446933.